Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)
Clinical trial NCT02342353 · TERMINATED
Trial details
- NCT number
- NCT02342353
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-18
- Primary completion
- 2018-02-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.